Ultima-Cialis 25 (EU) Ultima Pharmaceuticals

£70.00

Ultima-Cialis 25 is a tadalafil citrate research compound from Ultima Pharmaceuticals designed for erectile dysfunction mechanism studies. Laboratory-grade formulation for in-vitro investigation of PDE5 inhibition pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Cialis 25 (EU) Ultima Pharmaceuticals
Ultima-Cialis 25 (EU) Ultima Pharmaceuticals
£70.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Ultima-Cialis 25 (EU) Ultima Pharmaceuticals

Ultima-Cialis 25 is a tadalafil citrate research compound manufactured by Ultima Pharmaceuticals for laboratory investigation of phosphodiesterase type 5 (PDE5) inhibition mechanisms. This research chemical enables scientists to examine the molecular pathways involved in erectile dysfunction therapeutics and vascular smooth muscle regulation. The compound provides researchers with standardised tadalafil citrate for comprehensive studies into cyclic guanosine monophosphate (cGMP) pathway modulation. Investigations focus on understanding how selective PDE5 inhibition affects nitric oxide signalling cascades in cellular models. Research teams at Stroid UK Shop utilise this compound to analyse endothelial function and vascular biology mechanisms.

Laboratory Applications

Research applications include investigating PDE5 enzyme kinetics, studying cyclic nucleotide metabolism, and examining vascular endothelial responses in controlled laboratory environments. Scientists evaluate tadalafil’s selectivity profile compared to other phosphodiesterase inhibitors, particularly its effects on PDE6 and PDE11 isoforms. Cell culture studies examine the compound’s impact on smooth muscle relaxation pathways and nitric oxide-dependent signalling mechanisms. Comparative research explores duration of action differences between tadalafil and other PDE5 inhibitors in various tissue models. Researchers studying cialis research compounds analyse molecular binding affinity and pharmacokinetic properties. Additional studies investigate potential applications in pulmonary arterial hypertension research models and cardiac function analysis.

Product Specifications

Ultima-Cialis 25 Research Specifications
Parameter Value
Active Compound Tadalafil Citrate
Concentration 25mg per unit
Manufacturer Ultima Pharmaceuticals
Form Tablet formulation
CAS Number 171596-29-5
Molecular Formula C₂₂H₁₉N₃O₄ • C₆H₈O₇
Storage Requirements Room temperature, dry conditions
Research Grade Laboratory standard

Scientists studying advanced mechanisms also investigate selective androgen receptor modulators and peptide research compounds for comparative endocrine research applications.

Research Compliance

This product is strictly intended for in-vitro laboratory research and analytical testing purposes only. Not approved for human consumption, therapeutic use, or any clinical applications. Researchers must handle according to institutional safety protocols and applicable regulations governing research chemical usage.

Related